Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip B Hylemon

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
The American Journal of Gastroenterology|June 7, 2018
Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in CirrhosisJasmohan S Bajaj, Chathur Acharya, Andrew Fagan, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Bile acid dysmetabolism in Bangladeshi infants is associated with poor linear growth, enteric inflammation, and small intestine bacterial overgrowthFarah Hasan, Phillip B Hylemon, Rashidul Haque, et al.
Hepatology (Baltimore, Md.)|June 25, 2016
Gut microbiota drive the development of neuroinflammatory response in cirrhosis in miceDae Joong Kang, Naga S Betrapally, Siddhartha A Ghosh, et al.
Hepatology (Baltimore, Md.)|June 13, 2012
Astrocyte elevated gene-1 promotes hepatocarcinogenesis: novel insights from a mouse modelJyoti Srivastava, Ayesha Siddiq, Luni Emdad, et al.
Scientific Reports|December 7, 2016
Elderly patients have an altered gut-brain axis regardless of the presence of cirrhosisJasmohan S Bajaj, Vishwadeep Ahluwalia, Joel L Steinberg, et al.
Nature Communications|October 19, 2022
Reduced alcohol preference and intake after fecal transplant in patients with alcohol use disorder is transmissible to germ-free miceJennifer T Wolstenholme, Justin M Saunders, Maren Smith, et al.
Clinical and Translational Gastroenterology|August 26, 2016
Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota CompositionDae J Kang, Genta Kakiyama, Naga S Betrapally, et al.
Gut|June 15, 2022
Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSCMuyiwa Awoniyi, Jeremy Wang, Billy Ngo, et al.
Nature Microbiology|April 21, 2025
An expanded metabolic pathway for androgen production by commensal bacteriaTaojun Wang, Saeed Ahmad, Angélica Cruz-Lebrón, et al.
JCI Insight|November 22, 2019
Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosisJasmohan S Bajaj, Nita Salzman, Chathur Acharya, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
The American Journal of Gastroenterology|June 7, 2018
Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in CirrhosisJasmohan S Bajaj, Chathur Acharya, Andrew Fagan, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Bile acid dysmetabolism in Bangladeshi infants is associated with poor linear growth, enteric inflammation, and small intestine bacterial overgrowthFarah Hasan, Phillip B Hylemon, Rashidul Haque, et al.
Hepatology (Baltimore, Md.)|June 25, 2016
Gut microbiota drive the development of neuroinflammatory response in cirrhosis in miceDae Joong Kang, Naga S Betrapally, Siddhartha A Ghosh, et al.
Hepatology (Baltimore, Md.)|June 13, 2012
Astrocyte elevated gene-1 promotes hepatocarcinogenesis: novel insights from a mouse modelJyoti Srivastava, Ayesha Siddiq, Luni Emdad, et al.
Scientific Reports|December 7, 2016
Elderly patients have an altered gut-brain axis regardless of the presence of cirrhosisJasmohan S Bajaj, Vishwadeep Ahluwalia, Joel L Steinberg, et al.
Nature Communications|October 19, 2022
Reduced alcohol preference and intake after fecal transplant in patients with alcohol use disorder is transmissible to germ-free miceJennifer T Wolstenholme, Justin M Saunders, Maren Smith, et al.
Clinical and Translational Gastroenterology|August 26, 2016
Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota CompositionDae J Kang, Genta Kakiyama, Naga S Betrapally, et al.
Gut|June 15, 2022
Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSCMuyiwa Awoniyi, Jeremy Wang, Billy Ngo, et al.
Nature Microbiology|April 21, 2025
An expanded metabolic pathway for androgen production by commensal bacteriaTaojun Wang, Saeed Ahmad, Angélica Cruz-Lebrón, et al.
JCI Insight|November 22, 2019
Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosisJasmohan S Bajaj, Nita Salzman, Chathur Acharya, et al.
Pageof 13